Tumor microenvironment
TME analysis runs on the Computational Biology single-cell pipeline. Oncology adds the tumor biology layer — curated cancer reference signatures, cell-state scoring, and cohort comparison — without duplicating compbio clustering infrastructure.
What compbio provides
- QC, normalization, HVG selection, clustering, and marker identification
- UMAP exploration and differential expression
- Spatial transcriptomics when Visium/Xenium data is linked to the study
What oncology adds
- TME-oriented cell-type annotation using curated cancer reference signatures (tumor, immune, stromal, vascular compartments)
- Cell-state scoring — exhaustion, activation, differentiation, regulatory suppression — using published oncology gene sets
- Comparative TME composition across tumor types, treatment conditions, and responder/non-responder groups
Where to run TME analysis
Open the study TME page at /areas/oncology/studies/{id}/tme.
When single-cell data is linked to the study through compbio, launch clustering and annotation from the compbio study workspace, then review TME composition summaries in the oncology view.
Typical workflow
- Upload single-cell data via the compbio study linked to your oncology cohort
- Run compbio QC, normalization, and clustering
- Annotate cell types with oncology reference signatures
- Compare TME composition across treatment arms or response groups
- Feed annotated expression into Cell-cell communication
Spatial TME
Spatial data ingestion, tile generation, neighborhood analysis, and scRNA-seq deconvolution are handled by the compbio spatial pipeline. Oncology adds:
- Spatially-resolved immune infiltration, exclusion, and desert phenotype classification
- Tumor–immune boundary proximity scoring
- Spatial co-localization of ligand-receptor pairs
Pathology WSI overlays provide tissue morphology context — see the Pathology area documentation.
Next steps
- Cell-cell communication
- Immuno-oncology profiling
- Computational Biology Single-cell guide